Amalgamated Bank Sells 1,005 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Amalgamated Bank lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 36,348 shares of the company's stock after selling 1,005 shares during the quarter. Amalgamated Bank's holdings in HCA Healthcare were worth $10,910,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Keeler Thomas Management LLC acquired a new position in HCA Healthcare in the fourth quarter valued at about $797,000. IFP Advisors Inc raised its stake in HCA Healthcare by 23.2% during the fourth quarter. IFP Advisors Inc now owns 9,444 shares of the company's stock worth $2,835,000 after acquiring an additional 1,777 shares in the last quarter. Y Intercept Hong Kong Ltd raised its stake in HCA Healthcare by 209.0% during the fourth quarter. Y Intercept Hong Kong Ltd now owns 18,587 shares of the company's stock worth $5,579,000 after acquiring an additional 12,571 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new position in HCA Healthcare during the fourth quarter worth about $1,060,000. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund raised its stake in HCA Healthcare by 4.4% during the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 37,869 shares of the company's stock worth $11,366,000 after acquiring an additional 1,600 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have commented on HCA shares. StockNews.com downgraded HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Monday, November 4th. JPMorgan Chase & Co. restated a "neutral" rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Royal Bank of Canada reduced their price target on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a report on Monday, January 27th. Cantor Fitzgerald restated an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Finally, Truist Financial reduced their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $385.67.

HCA Healthcare Stock Down 4.7 %

Shares of NYSE:HCA traded down $15.16 during trading on Friday, reaching $305.79. 3,469,113 shares of the stock were exchanged, compared to its average volume of 1,740,103. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The stock has a fifty day moving average of $315.15 and a two-hundred day moving average of $349.52. The firm has a market cap of $75.94 billion, a price-to-earnings ratio of 13.92, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the business earned $5.90 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a $0.72 dividend. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare's dividend payout ratio is presently 13.11%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.